SCHEMBL978856

SCHEMBL978856

CC=C(NC(C)=O)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7828104 1.00
Alcohol SCHEMBL8740653 0.91
SCHEMBL23201163 0.81 CRBN (0.38)
SCHEMBL8626245 0.80
SCHEMBL31122193 0.79 CRBN (0.36)
SCHEMBL14036193 0.79 CRBN (0.36)
SCHEMBL14042848 0.79
SCHEMBL714084 0.77 CRBN (0.35)
SCHEMBL7748221 0.76 CRBN (0.50)
SCHEMBL7648853 0.76 CRBN (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3368593-B1 IMPROVED BINDER COMPOSITIONS AND USES THEREOF KNAUF INSULATION SPRL (BE) 2023-12-06 EP claimed
EP-2549564-B1 SEPARATOR AND ELECTROCHEMICAL DEVICE HAVING SAME LG CHEMICAL LTD (KR) 2016-10-12 EP claimed
WO-2011031453-A1 METHOD OF CHEMICALLY MODIFYING THE INTERNAL REGION OF A HAIR SHAFT THE PROCTER & GAMBLE COMPANY (US) 2011-03-17 WO claimed
EP-2295029-A1 Method of chemically modifying the internal region of a hair shaft The Procter & Gamble Company (US) 2011-03-16 EP claimed
WO-2024245839-A1 STABILIZATION OF URETHANE HYBRID RESIN SYSTEMS COVESTRO DEUTSCHLAND AG (DE) 2024-12-05 WO disclosed
EP-4467587-A1 STABILIZATION OF URETHANE HYBRID RESIN SYSTEMS Covestro Deutschland AG (DE) 2024-11-27 EP disclosed
EP-4214277-A1 SULFIDE-CONTAINING STABILIZER SYSTEM FOR THIOL-ENE AND THIOL-YNE COMPOSITIONS Bruno Bock GmbH (DE) 2023-07-26 EP disclosed
US-20230133011-A1 MULTIFUNCTIONAL CYTOPROTECTANT FOR TREATMENT OF PATHOGENIC PROCESSES MEDIATED BY OXIDATIVE STRESS AND TOXIC ELECTROPHILES MONTEFIORE MEDICAL CENTER (US) 2023-05-04 US disclosed
US-11413255-B2 Multifunctional cytoprotectant for treatment of pathogenic processes mediated by oxidative stress and toxic electrophiles MONTEFIORE MEDICAL CENTER (US) 2022-08-16 US disclosed
CN-113373466-A Electrochemical synthesis method of beta-acetaminocarbonyl compound 安徽科技学院 2021-09-10 CN disclosed
US-10996496-B2 Composite film, device including, and method of forming the same NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2021-05-04 US disclosed
WO-2021040349-A1 NOVEL HEPSIN INHIBITOR AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS EFFECTIVE COMPONENT FOR PREVENTING OR TREATING METASTATIC CANCER 고려대학교 세종산학협력단 2021-03-04 WO disclosed
WO-2000015341-A2 METHOD FOR PRODUCING ACTIVE AND/OR SELECTIVE SOLID CATALYSTS FROM INORGANIC OR ORGANOMETALLIC MATERIALS INSTITUT FüR ANGEWANDTE CHEMIE BERLIN-ADLERSHOF E.V. (DE) 2000-03-23 WO disclosed
WO-2000014096-A1 FERROCENE-BASED DIPHOSPHONITES FOR ASYMMETRICAL CATALYSIS STUDIENGESELLSCHAFT KOHLE MBH (DE) 2000-03-16 WO disclosed
WO-2000001692-A1 SALTS OF PAROXETINE SMITHKLINE BEECHAM PLC (GB) 2000-01-13 WO disclosed
US-5827794-A SULFONATED 2,2'-BIS(DIPHENYLPHOSPHINO)-1,1'-BINAPHTHYL CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 1998-10-27 US disclosed
US-5756838-A Method of asymmetrically synthesizing optically active compounds using supported phase chiral sulfonated BINAP catalyst CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 1998-05-26 US disclosed
EP-0746410-A4 WATER-SOLUBLE CHIRAL SULFONATED BINAP CATALYST FOR ASYMMETRIC SYNTHESIS OF OPTICALLY ACTIVE COMPOUNDS CALIFORNIA INST OF TECHN (US) 1997-04-09 EP disclosed
EP-0746410-A1 WATER-SOLUBLE CHIRAL SULFONATED BINAP CATALYST FOR ASYMMETRIC SYNTHESIS OF OPTICALLY ACTIVE COMPOUNDS CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 1996-12-11 EP disclosed
WO-1995022405-A1 WATER-SOLUBLE CHIRAL SULFONATED BINAP CATALYST FOR ASYMMETRIC SYNTHESIS OF OPTICALLY ACTIVE COMPOUNDS CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 1995-08-24 WO disclosed